tradingkey.logo
tradingkey.logo

Kestra Medical Technologies Ltd

KMTS
View Detailed Chart
19.460USD
-0.220-1.12%
Close 03/27, 16:00ETQuotes delayed by 15 min
963.93MMarket Cap
LossP/E TTM

Kestra Medical Technologies Ltd

19.460
-0.220-1.12%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.12%

5 Days

+1.88%

1 Month

-16.41%

6 Months

-20.02%

Year to Date

-26.62%

1 Year

-16.94%

View Detailed Chart

Key Insights

Kestra Medical Technologies Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 40 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.71.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Kestra Medical Technologies Ltd's Score

Industry at a Glance

Industry Ranking
40 / 208
Overall Ranking
130 / 4542
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Kestra Medical Technologies Ltd Highlights

StrengthsRisks
Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Growing
The company is in a growing phase, with the latest annual income totaling USD 59.81M.
Overvalued
The company’s latest PE is -7.05, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 50.44M shares, increasing 1.88% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.27M shares of this stock.

Analyst Rating

Based on 7 analysts
Buy
Current Rating
28.714
Target Price
+45.91%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Kestra Medical Technologies Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Kestra Medical Technologies Ltd Info

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Ticker SymbolKMTS
CompanyKestra Medical Technologies Ltd
CEOWebster (Brian Daniel)
Website
KeyAI